Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme

FEMS Immunology and Medical Microbiology

Volumn 48, Issue 2, 2006, Pages 179-182

  Levidiotou, Stamatina ^a   Vrioni, Georgia ^a   Tzanakaki, Georgina ^b   Pappa, Christina ^a   Gesouli, Helen ^a   Gartzonika, Constantina ^a   Papamichail, Dimitrios ^a   Kremastinou, Jenny ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

Author keywords

Antibiotics; Children; Serotypes; Streptococcus pneumoniae; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LINEZOLID; PENICILLIN G; STREPTOCOCCUS VACCINE; VANCOMYCIN;

ACUTE OTITIS MEDIA; ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BLOOD CULTURE; CEREBROSPINAL FLUID; CHILD; DISEASE CARRIER; GREECE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE EAR EFFUSION; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADOLESCENT; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; GREECE; HUMANS; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 33750073173     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00126.x     Document Type: Article

References (17)

1. Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J & Doern GVThe GRASP Study Group (2005) Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003 Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 25: 148-156.
2. Centers for Disease Control and Prevention (2005) Recommended Childhood and Adolescent Immunization Schedule - United States. MMWR 53: Q1-Q3.
3. Fotopoulou N, Tsiplakou S, Maniatis AN, Pangali A, Kouppari G, Legakis NJ & Tassios PT (1999) Gradual increase in the minimum inhibitory concentration of penicillin among both susceptible and resistant Streptococcus pneumoniae isolates from Greek children during 1995-1997. Int J Antimicrob Agents 11: 53-57.
4. Hausdorff WP, Feikin DR & Klugman KP (2005) Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 5: 83-93.
5. Jacobs MR, Felmingham D, Appelbaum PC & Gruneberg RNThe Alexander Project Group (2003) The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 52: 229-246.
6. Jones ME, Blosser-Middleton RS, Critchley IA, Karlowsky JA, Thornsberry C & Sahm DF (2003) In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001. Clin Microbiol Infect 9: 590-599.
7. Kouppari G, Zaphiropoulou A, Stamos G, Deliyianni V, Apostolopoulos N & Legakis NJ (2000) Pneumococcal acute otitis media in children. Clin Microbiol Infect 6: 69-73.
8. Kouppari G, Zaphiropoulou A, Tsolia M, Apostolopoulos N, Deliyianni V & Kafetzis D (1998) Serotyping and antibiotic resistance of Streptococcus pneumoniae isolated from pediatric infections in central Greece. Clin Microbiol Infect 4: 695-700.
9. Malfroot A, Verhaegen J, Dubru JM, Van Kerschaver E & Leyman S (2004) A cross-sectional survey of the prevalence of Streptococcus pneumoniae nasopharyngeal carriage in Belgian infants attending day care centres. Clin Microbiol Infect 10: 797-803.
10. National Committee for Clinical Laboratory Standards (2002) Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. Standards. M100-S12. NCCLS, Wayne, PA.
11. Reinert RR (2004) Pneumococcal conjugate vaccines - a European perspective. Int J Med Microbiol 294: 277-294.
12. Serrano I, Ramirez M & Melo-Cristino JThe Portuguese Surveillance Group for the Study of Respiratory Pathogens (2004) Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy. Clin Microbiol Infect 10: 652-656.
13. Sorensen UBS (1993) Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 31: 2097-2100.
14. Syriopoulou V, Daikos GL, Soulis K, Michos A, Alexandrou H, Pavlopoulou I, Pagali IPA, Hadjichristodoulou C & Theodoridou M (2000) Epidemiology of invasive childhood pneumococcal infections in Greece. Acta Paediatr 89: 30-34.
15. Syrogiannopoulos GA, Katopodis GD, Grivea IN & Beratis NG (2002) Antimicrobial use and serotype distribution of nasopharyngeal Streptococcus pneumoniae isolates recovered from Greek children younger than 2 years old. Clin Infect Dis 35: 1174-1182.
16. Tsolia MN, Stamos G, Ioannidou S, Trefler R, Foustoukou M, Kafetzis D & Porat N (2002) Genetic relatedness of resistant and multiresistant Streptococcus pneumoniae strains, recovered in the Athens area, to international clones. Microb Drug Resist 8: 219-226.
17. Zissis NP, Syriopoulou V, Kafetzis D, Daikos GL, Tsilimingaki A, Galanakis E & Tsangaropoulou I (2004) Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children. Eur J Pediatr 163: 364-368.